The predictive value of angiogenesis for adjuvant therapy in breast cancer.

This publication has 11 references indexed in Scilit:

• p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma
  International Journal of Cancer, 2000
• Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma
  Cancer, 1999
• Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
  Journal of Clinical Oncology, 1998
• p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.
  Journal of Clinical Oncology, 1998
• Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF
  Annals of Oncology, 1997
• Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
  JNCI Journal of the National Cancer Institute, 1997
• Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications.
  Angiogenesis, 1997
• Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis
  Breast Cancer Research and Treatment, 1996
• Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase
  British Journal of Cancer, 1995
• Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1995